OMNIPOD INSULIN MANAGEMENT SYSTEM 19191 ZXP425

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a consumer report with the FDA on 2020-03-31 for OMNIPOD INSULIN MANAGEMENT SYSTEM 19191 ZXP425 manufactured by Insulet Corporation.

MAUDE Entry Details

Report Number3004464228-2020-04714
MDR Report Key9908728
Report SourceCONSUMER
Date Received2020-03-31
Date of Report2020-03-12
Date of Event2020-03-12
Date Mfgr Received2020-03-12
Device Manufacturer Date2019-10-16
Date Added to Maude2020-03-31
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactJORDAN BISWURM
Manufacturer Street100 NAGOG PARK
Manufacturer CityACTON MA 01720
Manufacturer CountryUS
Manufacturer Postal01720
Manufacturer Phone9786007000
Manufacturer G1INSULET CORPORATION
Manufacturer Street100 NAGOG PARK
Manufacturer CityACTON MA 01720
Manufacturer CountryUS
Manufacturer Postal Code01720
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameOMNIPOD INSULIN MANAGEMENT SYSTEM
Generic NamePUMP, INFUSION, INSULIN
Product CodeLZG
Date Received2020-03-31
Model Number19191
Catalog NumberZXP425
Lot NumberL45199
OperatorLAY USER/PATIENT
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerINSULET CORPORATION
Manufacturer Address100 NAGOG PARK ACTON MA 01720 US 01720


Patients

Patient NumberTreatmentOutcomeDate
10 2020-03-31

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.